Feb 4 • 08:35 UTC 🇬🇷 Greece Naftemporiki

Novo Nordisk: 18% 'plunge' in stocks after the 'cold shower' for 2026 forecasts

Novo Nordisk's shares fell 18% in Copenhagen following disappointing 2026 projections, signaling a challenging year for weight-loss market players despite previous optimism from strong sales of the Wegovy pill.

📡 Similar Coverage